Abstract:Abstract Background Accurate risk assessment is essential for the primary prevention of cardiovascular disease (CVD). The commonly used models (e.g., WHO CVD risk charts and SCORE2) have been recalibrated using country-specific incidence to reduce the impact of population disparity. While some state-of-art machine learning algorithms have been developed to improve predictive accuracy, it is still unclear if they could accurately predict CVD risk in diverse populations. How to recalibrate these models for CVD risk prediction remains unknown. Purpose To adapt the recalibration method for survival neural network and assess its capability to predict 10-year CVD risk in UK and Chinese populations. Methods We selected adults aged 40-74 years without prior CVD from UK Biobank cohort and CHERRY cohort, an electronic health records-based Chinese cohort. 80% of participants of UKB cohort were used for model derivation, the rest were for internal validation, and the CHERRY cohort was for external validation. We used two different models of survival neural networks: ⑴ deepsurv which models the hazard function using Cox regression; ⑵ deephit which directly learns the distribution of survival time. Our models were based on predictors such as sex, age, smoking status, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol and history of diabetes. Model performance was evaluated in discrimination, calibration and reclassification compared with a Cox regression model. We recalibrated neural network models using the population-based incidence rate estimated from the CHERRY cohort. Results 347,206 participants from the UKB cohort (median[p25-p75] age:58[50-63]; women:54.7%) and 177,756 participants from the CHERRY cohort (median[p25-p75] age:55[48-62]; women:53.6%) were included for analyses. The 10-year Kaplan-Meier CVD rate was higher in CHERRY than in UKB (8.03%vs.3.66%). Using the same traditional CVD risk factors, compared to Cox regression, neural network models had higher C statistics in both UKB (0.732-0.734 vs. 0.731,P<0.001) and CHERRY cohorts (0.727-0.736 vs. 0.726,P<0.001). All models were well-calibrated in UKB, but underpredicted risk by around 60% (expected-observed ratio: 0.41-0.42) in CHERRY. Population-based recalibration yields substantial improvement (expected-observed ratio: 0.87-0.93). Moreover, recalibrated neural network models showed improved reclassification compared to Cox regression (the net reclassification improvements:1.89%-7.52% in UKB, 4.31%-5.17% in CHERRY), with a more distinct distribution of predicted risk. Conclusion Survival neural networks showed good discrimination in CVD risk prediction and consistently ranked low- and high-risk individuals across diverse populations. Like traditional regression, these models also need to be rescaled to adapt to the risk characteristics of the target population, and recalibration using population-based data could be a feasible method.Discrimination and calibrationRisk distribution and reclassification

The Application of Radial Basis Function Network in Cardiovascular Risk Stratification

Artificial Neural Network Based Model for Cardiovascular Risk Stratification in Hypertension.

A Computational Model for Heart Failure Stratification

Cardiovascular Risk Prediction Method Based On Cfs Subset Evaluation And Random Forest Classification Framework

Improving Cardiovascular Risk Prediction Through Machine Learning Modelling of Irregularly Repeated Electronic Health Records

Novel Data Classification Method Based on Radial Basis Function Networks

Health Big Data Classification Using Improved Radial Basis Function Neural Network and Nearest Neighbor Propagation Algorithm

Financial Risk Analytics Based On Radial Basis Function Neural Network

Rationale and design of the application value of Beijing Vascular Health Stratification (BVHS): predictive value of combined assessment of vascular structure and function for cardiovascular events in general Chinese population

Machine Learning-Based Decision-Making Mechanism for Risk Assessment of Cardiovascular Disease

Study of cardiovascular disease prediction model based on random forest in eastern China

Diagnosis of Congestive Heart Failure Based on BP Network with Multiple Heart Rate Variability Parameters

Using machine learning models to improve stroke risk level classification methods of China national stroke screening

Application of RBF neural network optimal segmentation algorithm in credit rating

Enhanced Cardiovascular Monitoring Using Radial Basis Function and Deep Belief Network Fusion

Multi‐modality machine learning approach for risk stratification in heart failure with left ventricular ejection fraction ≤ 45%

Application of radial basis function neural network to estimate glomerular filtration rate in Chinese patients with chronic kidney disease

Performance of survival neural networks in predicting 10-year cardiovascular disease risk in UK and Chinese populations

Improving cardiovascular risk stratification with ECG-predicted risk factors in primary prevention

A machine learning-based risk stratification tool for in-hospital mortality of intensive care unit patients with heart failure

The Application of Rough Set-Neural Network Based on c-Means Clustering in Heart Disease Diagnosation